Biotech startups that raised Series B in Guangdong, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Medefa | Zhuhai | Series B | $14.9M | 2026-09-02 |
| Hongxin Biology | Shenzhen | Series B | $14.0M | 2026-08-13 |
| Salus BioMed | Shenzhen | Series B | $7.0M | 2025-10-09 |
| EurekaBio | Shenzhen | Series B | $41.7M | 2024-02-21 |
| Energae | Shenzhen | Series B | $1.4M | 2023-12-23 |
| Reetoo Biotech | Shenzhen | Series B | $14.0M | 2023-12-18 |
| ME Instruments | Shenzhen | Series B | $14.1M | 2023-12-15 |
| Xbiome | Shenzhen | Series B | $100.0M | 2021-12-22 |
8 rows of the CSV in 5 of its 18 columns.
- The 39 biotech startups in Guangdong, China whose last round is Series B have raised $2.9B in total.
- 5 of them closed their most recent round in the last 12 months, $189.4M combined.
- The largest of those rounds is Syneron's $150.0M Series B, dated March 2026.
- The most recent is Hipower's $10.5M Series B on 19 October 2026.
- Health care is the most common other sector, with 35 companies (90%).
- 13% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 51 to 100 employees (35% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
2 of 39| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Medefa | Medefa uses synthetic biology to mass-produce novel PHA biomaterials. | Biotech | Zhuhai | Series B | $14.9M | 2026-09-02 | $16.3M | Motianshi Touzi, Taiping Innovation | 11 to 50 | 2019 |
| Hongxin Biology | Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. | Biotech | Shenzhen | Series B | $14.0M | 2026-08-13 | $14.0M | Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | 11 to 50 | 2021 |
Table 1. Biotech startups that raised Series B in Guangdong, China: the 2 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 39.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Medefa | Medefa uses synthetic biology to mass-produce novel PHA biomaterials. | Biotech | Zhuhai | Series B | $14.9M | 2026-09-02 | $16.3M | Motianshi Touzi, Taiping Innovation | 11 to 50 | 2019 |
| 2 | Hongxin Biology | Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. | Biotech | Shenzhen | Series B | $14.0M | 2026-08-13 | $14.0M | Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | 11 to 50 | 2021 |
Table 2. Biotech startups that raised Series B in Guangdong, China: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Taiping Innovation | Private equity firm | 1 | 3% | 1 | Medefa | |
| 2 | Motianshi Touzi | Guangzhou, China | 1 | 3% | 1 | Medefa | |
| 3 | Haiyuan Capital | Venture capital firm | Shenzhen, China | 1 | 3% | 1 | Hongxin Biology |
| 4 | Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | Micro VC fund | Shenzhen, China | 1 | 3% | 1 | Hongxin Biology |
| 5 | Wanlian Tianze | Venture capital firm | Guangzhou, China | 1 | 3% | 1 | Huateng Biotech |
| 6 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 1 | 3% | ||
| 7 | GreatWall Fund | Venture capital firm | Shenzhen, China | 1 | 3% | ||
| 8 | Qianhai Fund of Funds | Private equity firm | Shanzhen, China | 1 | 3% | ||
| 9 | ZhenFund | Entrepreneurship program | Beijing, China | 1 | 3% | ||
| 10 | BioTrack Capital | Venture capital firm | Shanghai, China | 1 | 3% | ||
| 11 | ABC Capital | Private equity firm | Shanghai, China | 1 | 3% | ||
| 12 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | 1 | 3% | ||
| 13 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 1 | 3% | ||
| 14 | Guangzhou Yuexiu Industrial Investment Fund | Corporate venture arm | Guangzhou, China | 1 | 3% | ||
| 15 | Tailing Holdings | 1 | 3% |
Table 3. Biotech startups that raised Series B in Guangdong, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 35 | 90% | $1.8B |
| Artificial intelligence | 4 | 10% | $388.2M |
| Software | 4 | 10% | $388.2M |
| Energy | 1 | 3% | $816.8M |
Table 4. Biotech startups that raised Series B in Guangdong, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 39 | 100% | $14.1M |
Table 5. Biotech startups that raised Series B in Guangdong, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Shenzhen | 18 | 46% |
| Guangzhou | 11 | 28% |
| Zhuhai | 3 | 8% |
| Tianjin | 3 | 8% |
| Nanshanqu | 2 | 5% |
| Huangpu | 1 | 3% |
| Pingshan | 1 | 3% |
Table 6. Biotech startups that raised Series B in Guangdong, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 20% | $10.5M |
| September 2026 | 1 | 20% | $14.9M |
| August 2026 | 1 | 20% | $14.0M |
| March 2026 | 1 | 20% | $150.0M |
| January 2026 | 1 | 20% |
Table 7. Biotech startups that raised Series B in Guangdong, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 13% | $189.4M |
| 2025 | 4 | 10% | $117.3M |
| 2024 | 3 | 8% | $83.0M |
| 2023 | 7 | 18% | $44.0M |
| 2022 | 7 | 18% | $791.0M |
| 2021 | 2 | 5% | $115.5M |
Table 8. Biotech startups that raised Series B in Guangdong, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 5 | 13% |
| 2015 to 2019 | 18 | 47% |
| 2010 to 2014 | 5 | 13% |
| Before 2010 | 10 | 26% |
Table 9. Biotech startups that raised Series B in Guangdong, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 1 | 3% |
| 11 to 50 | 9 | 24% |
| 51 to 100 | 13 | 35% |
| 101 to 250 | 8 | 22% |
| 251 to 500 | 4 | 11% |
| 501 to 1,000 | 1 | 3% |
| 1,001 to 5,000 | 1 | 3% |
Table 10. Biotech startups that raised Series B in Guangdong, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series B and its headquarters is in Guangdong, China. On 16 November 2026 that is 39 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 2 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 39 rows: 9 have no round amount, 0 no city and 11 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Guangdong, China whose last round is Series B are on the list?
- 39, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 39 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.